Idera Pharmaceuticals Inc. (Nasdaq: IDRA) reported positive preclinical data for its cancer treatment IMO-2055. The stock price rose 49 cents to close at $4.07.
Idera reports positive data
December 03, 2014 at 17:31 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.